Maxygen News

News on Maxygen (Ticker: MAXY) continually updated from thousands of sources around the net.

Thursday May 17 | PR-inside.com

Maxygen, Inc. - SWOT Analysis - new company profile report published

Maxygen, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information.

Comment?

Related Topix: Startups, San Mateo, CA

Tue May 15, 2012

BioResearch Online

Maxygen To Receive $30M Payment From Bayer

Maxygen, Inc. , a biopharmaceutical company, today announced that it will receive a $30.0 million payment from Bayer HealthCare LLC in connection with Bayer's continued clinical development of a recombinant factor VIIa product candidate for the treatment of hemophilia.

Comment?

Related Topix: Startups, Hematology, Medicine

Mon May 07, 2012

Freshnews

Maxygen Reports First Quarter 2012 Financial Results

SAN MATEO, Calif. -- -- Maxygen, Inc. , a biopharmaceutical company, today announced financial and business results for the quarter ended March 31, 2012.

Comment?

Wed May 02, 2012

Seeking Alpha

Maxygen: Bayer $30 Million Payment Likely In 2012

I have previously written on why I think that Maxygen, Inc. is an attractive long with minimal downside, and the articles are available here and here .

Comment?

Related Topix: Startups, Manufacturing, Bayer HealthCare, Chemicals